THC combined with the chemotherapy drug irinotecan worsened white blood cell drops in rats but appeared to protect against liver enzyme elevation.
Cancer patients and oncologists interested in cannabis-chemotherapy interactions.
THC metabolite levels were higher when combined with irinotecan, suggesting a pharmacokinetic interaction between the two drugs.
What the researchers found
Co-administration of THC with irinotecan in rats caused greater leukopenia than irinotecan alone, but the expected rise in the liver enzyme AST seen with irinotecan alone did not occur in the combination group.
Why it matters
Many cancer patients use cannabis to manage chemotherapy side effects. This study suggests THC may have both helpful and harmful interactions with at least one chemo drug, highlighting the need to understand these interactions before combining treatments.
The numbers in context
THC dose was 7 mg/kg orally. Irinotecan dose was 100 mg/kg. Urinary THC metabolite concentrations were higher in the irinotecan + THC group compared to THC-only, suggesting a pharmacokinetic interaction.
How the study worked
Male rats received single-dose irinotecan alone or with repeated oral THC (1, 3, or 7 days). Blood and urine were analyzed for blood counts, liver enzymes, inflammatory markers, and THC metabolites.
What this study cannot tell us
Animal study using a single chemo drug and relatively high doses. Results may not translate directly to humans. Only male rats were studied. Short follow-up period.
How to read the evidence
Preliminary - single animal study with a small sample.
When this study was published
Published in 2018. More research has since explored cannabinoid-chemotherapy interactions.
The bigger picture
As cannabis use among cancer patients increases, understanding how cannabinoids interact with chemotherapy drugs becomes critical. This study provides early evidence that THC may alter both the effectiveness and toxicity profile of irinotecan.
Questions still open
- Does THC interact similarly with other chemotherapy drugs? Would lower, more clinically relevant THC doses produce the same effects? What mechanism drives the protective liver effect versus the worsened blood cell counts?
Common questions
Can you use cannabis while on chemotherapy?
Does THC affect how chemo drugs are processed in the body?
Read the original research
Effects of Δ9-tetrahydrocannabinol on irinotecan-induced clinical effects in rats.
Chemico-biological interactions, 294, 128-134
Citation
Prester, Ljerka; Mikolić, Anja; Jurič, Andreja; Fuchs, Nino; Neuberg, Marijana; Lucić Vrdoljak, Ana; Brčić Karačonji, Irena. (2018). Effects of Δ9-tetrahydrocannabinol on irinotecan-induced clinical effects in rats.. Chemico-biological interactions, 294, 128-134. https://doi.org/10.1016/j.cbi.2018.08.009
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk